Floatz logo

11 assets in Mood Disorder

Therapeutic assets addressing Mood Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Quetiapine
Mood Disorder
First Affiliated Hospital of Zhejiang UniversityP4BB (71)
Escitalopram
Mood Disorder
First Affiliated Hospital of Zhejiang UniversityP3BB (64)
Lurasidone
Mood Disorder
First Affiliated Hospital of Zhejiang UniversityP2B (57)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Mood Disorder
King's College LondonP1/2CCC (52)
(2R,6R)-HYDROXYNORKETAMINE
Mood Disorder
National Institute of Mental Health (NIMH)P2CCC (52)
ly03010
Mood Disorder
Luye Pharma Group Ltd.P1CCC (52)
Teonanacatl
Mood Disorder
University Health Network, TorontoP2CCC (52)
Dinitrogen Monoxide
Mood Disorder
Washington University School of MedicineP1CC (43)
Levonorgestrel
Mood Disorder
Rigshospitalet, DenmarkN/AD (30)
Midazolam
Mood Disorder
King's College LondonN/AD (30)